Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
American Journal of Epidemiology|August 2, 2014
An updated natural history model of cervical cancer: derivation of model parametersNicole G Campos, Emily A Burger, Stephen Sy, et al.
Journal of the National Cancer Institute|November 25, 2010
Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortMahboobeh Safaeian, Koen Quint, Mark Schiffman, et al.
The Journal of Infectious Diseases|January 13, 2009
Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycleMahboobeh Safaeian, Roni T Falk, Ana Cecilia Rodriguez, et al.
Journal of Lower Genital Tract Disease|June 25, 2009
Treatability by cryotherapy in a screen-and-treat strategyJulia C Gage, Ana Cecilia Rodriguez, Mark Schiffman, et al.
The Journal of Infectious Diseases|May 5, 2005
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa RicaPhilip E Castle, Mark Schiffman, Rolando Herrero, et al.
NPJ Digital Medicine|November 18, 2022
Improving the repeatability of deep learning models with Monte Carlo dropoutAndreanne Lemay, Katharina Hoebel, Christopher P Bridge, et al.
Journal of the National Cancer Institute|January 20, 2005
A study of the impact of adding HPV types to cervical cancer screening and triage testsMark Schiffman, Michelle J Khan, Diane Solomon, et al.
Plos One|July 14, 2012
The cervical microbiome over 7 years and a comparison of methodologies for its characterizationBenjamin C Smith, Thomas McAndrew, Zigui Chen, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Comparison of ophthalmic sponges for measurements of immune markers from cervical secretionsPhilip E Castle, Ana-Cecilia Rodriguez, Frederick P Bowman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 20, 2003
A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitationPatti E Gravitt, Robert D Burk, Attila Lorincz, et al.
Pageof 10